You might not want to share your "bleak" forecast but I am more than happy to share mine.
The production forecast downgrade was disappointing but not totally unexpected due to labor shortages re covid and this will improve as the WA border reopens.
Slide 9 in the presentation states that the spod price Jan/Mar is expected to be in the range US$2600-$3000 and that increase will help offset the lower production.
Full Year Forecast 2021/22
Production 360,000
Av Spod price US$2050
EBITDAX AUD$730M
NPAT AUD $500M
PE 16.6
So if the Spodumene price holds up and production targets are achieved we will be looking at very low PE ratios, lots of surplus cash and very healthy dividends.
Ann: FY22 December 2021 Half Year Results Presentation, page-13
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.75 |
Change
-0.090(3.17%) |
Mkt cap ! $8.279B | |||
| Open | High | Low | Value | Volume |
| $2.83 | $2.83 | $2.74 | $55.00M | 19.77M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 281921 | $2.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.77 | 221281 | 8 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| PLS (ASX) Chart |